← BRASKEM SA
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Revenue | $47.7b | $49.3b | $58.0b | $52.3b | $58.5b | $105.6b | $96.5b | $70.6b | $77.4b | $70.7b | |
| Total Revenue | $47.7b | $49.3b | $58.0b | $52.3b | $58.5b | $105.6b | $96.5b | $72.3b | $77.4b | $70.7b | |
| Net sales and services revenue | $47.7b | $49.3b | $58.0b | $52.3b | $58.5b | $105.6b | $96.5b | $70.6b | $77.4b | $70.7b | |
| Revenue From Interest | $646.7m | $512.1m | — | — | — | — | — | — | — | — | |
| Cost of Goods and Services Sold | $35.0b | $36.2b | $46.4b | $45.9b | $47.3b | $73.6b | $85.2b | $67.5b | $71.4b | $57.1b | |
| Gross Profit | $12.7b | $13.1b | $11.6b | $6.4b | $11.2b | $32.1b | $11.4b | $3.0b | $6.0b | $1.6b | |
| Research and development | ($162.0m) | ($167.5m) | ($199.8m) | ($247.7m) | ($250.6m) | ($296.6m) | ($374.5m) | ($383.0m) | ($463.0m) | ($460.0m) | |
| EBIT | $3.4b | ($1.9b) | ($12.3b) | $2.4b | |||||||
| Operating Income | — | — | — | — | — | — | $6.1b | ($1.8b) | ($990.0m) | ($1.6b) | |
| Additional Financial Items | |||||||||||
| (Loss) before financial results and taxes | $6.0b | $9.2b | $8.3b | $153.7m | ($71.9m) | $26.0b | $4.3b | ($2.8b) | ($1.1b) | ($1.8b) | |
| (Loss) before income tax | ($140.0m) | $5.3b | $3.6b | ($4.6b) | ($9.7b) | $18.0b | $47.3m | ($6.2b) | ($17.7b) | ($2.8b) | |
| Applicable Tax Rate | — | $0 | — | — | — | — | — | — | — | — | |
| Average Effective Tax Rate | $0 | $3.9b | $2.8b | $0 | $0 | $0 | $18 | $0 | $0 | — | |
| Depreciation Right of Use Assets | — | — | $2.8b | $500.8m | $740.2m | ($877.0m) | ($995.3m) | $1.3b | $1.1b | — | |
| Derivatives and exchange rate variations, net | ($3.2b) | ($798.8m) | ($2.3b) | ($1.7b) | ($5.3b) | ($4.0b) | ($572.2m) | $511.0m | ($11.5b) | $3.5b | |
| Finance Income | $690.1m | $603.6m | $589.1m | $850.6m | $600.2m | $1.8b | $2.0b | $1.7b | $1.7b | $2.3b | |
| General and administrative | ($1.3b) | ($1.4b) | ($1.6b) | ($2.2b) | ($1.9b) | ($2.5b) | ($2.8b) | ($2.5b) | ($2.6b) | ($2.6b) | |
| Income from Equity Method Investments | $30.1m | $40.0m | ($888k) | $10.2m | ($19.4m) | $4.6m | $34.8m | $7.0m | ($21.0m) | $9.0m | |
| Income taxes | ($616.0m) | ($1.4b) | ($736.6m) | $2.0b | $2.7b | ($4.0b) | ($867.7m) | $1.3b | $5.7b | ($8.1b) | |
| Interest Income | $690.1m | $603.6m | $589.1m | $850.6m | $600.2m | $1.8b | $2.0b | $1.7b | $1.7b | $2.3b | |
| Loss for the year | ($729.2m) | $3.9b | $2.9b | ($2.6b) | ($7.0b) | $14.0b | ($820.4m) | ($4.9b) | ($12.1b) | ($11.0b) | |
| Non-controlling interest in subsidiaries | ($317.7m) | $50.3m | $40.5m | ($99.4m) | ($323.6m) | ($23.3m) | ($484.7m) | ($311.0m) | ($732.0m) | ($1.1b) | |
| Other Income | — | $314.9m | $1.0b | $2.4b | $750.7m | $1.5b | $507.3m | $1.8b | $978.0m | $3.2b | |
| Profit Loss Attributable To Noncontrolling Interests | ($317.7m) | $50.3m | $40.5m | ($99.4m) | ($323.6m) | ($23.3m) | ($484.7m) | ($311.0m) | ($732.0m) | ($1.1b) | |
| Profit Loss Attributable To Owners Of Parent | ($411.5m) | $3.9b | $2.8b | ($2.5b) | ($6.7b) | $14.0b | ($335.7m) | ($4.6b) | ($11.3b) | ($9.9b) | |
| Profit Loss Before Tax | ($140.0m) | $5.3b | $3.6b | ($4.6b) | ($9.7b) | $18.0b | $47.3m | ($6.2b) | ($17.7b) | ($2.8b) | |
| Profit Loss From Operating Activities | $6.0b | $9.2b | $8.3b | $153.7m | ($71.9m) | $26.0b | $4.3b | ($2.8b) | ($1.1b) | ($1.8b) | |
| Reversal of (loss for) impairment of trade accounts receivable and others from clients | — | — | — | — | — | — | ($38.0m) | ($83.0m) | $108.0m | ($125.0m) | |
| Selling and distribution | ($1.4b) | ($1.5b) | ($1.5b) | ($1.8b) | ($1.9b) | ($2.1b) | ($2.1b) | ($1.9b) | ($2.0b) | ($2.1b) | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | $30.1m | $40.0m | ($888k) | $10.2m | ($19.4m) | $4.6m | $34.8m | $7.0m | ($21.0m) | $9.0m | |
| Net Income | ($411.5m) | $3.9b | $2.8b | ($2.5b) | ($6.7b) | $14.0b | ($336.0m) | ($4.6b) | ($11.3b) | ($9.9b) | |
| Net Income Common Stockholders | ($411.5m) | $3.9b | $2.8b | ($2.5b) | ($6.7b) | $14.0b | ($336.0m) | ($4.6b) | ($11.3b) | ($9.9b) | |
| Basic Earnings (Loss) Per Share | ($0.52) | $4.86 | $3.55 | ($3.19) | ($8.41) | $17.57 | ($1.26) | ($17.24) | ($42.60) | ($37.18) | |
| Diluted Earnings (Loss) Per Share | ($0.52) | $4.86 | $3.55 | ($3.19) | ($8.41) | $17.57 | ($1.26) | ($17.24) | ($42.60) | ($37.18) | |
| Administrative Expense | $1.3b | $1.4b | — | — | — | — | — | — | — | — | |
| Cost of products sold | ($35.0b) | ($36.2b) | ($46.4b) | ($45.9b) | ($47.3b) | ($73.6b) | ($85.2b) | ($67.5b) | ($71.4b) | ($69.2b) | |
| Current Tax Expense (Income) | ($411.5m) | $3.9b | $509.8m | ($228.9m) | ($52.8m) | ($3.8b) | ($1.0b) | ($191.0m) | — | — | |
| Deferred Tax Expense (Income) | ($411.5m) | — | $226.8m | $2.2b | $2.7b | ($165.0m) | $136.0m | $1.5b | $6.5b | — | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | $140.0m | $5.3b | ($235.5m) | $4.6b | $9.7b | $18.0b | $47.3m | $6.2b | $17.7b | $2.8b | |
| Depreciation And Amortisation Expense | ($2.7b) | ($2.9b) | — | — | — | — | — | — | — | — | |
| Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used | — | — | — | $1.1m | $981k | $7.2b | $42.0m | — | — | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | — | — | $103.9m | — | — | — | — | — | — | |
| Finance Costs | $3.6b | $3.7b | $3.0b | $3.9b | $4.9b | $5.9b | $5.7b | $5.6b | $6.9b | — | |
| Financial expenses | ($3.6b) | ($3.7b) | ($3.0b) | ($3.9b) | ($4.9b) | ($5.9b) | ($5.7b) | ($5.6b) | ($6.9b) | ($6.8b) | |
| General And Administrative Expense | $191.6m | — | $1.6b | $2.2b | $1.9b | $2.5b | $2.8b | $2.5b | $2.6b | $2.6b | |
| Income Tax Expense Continuing Operations | $616.0m | $1.4b | $736.6m | ($2.0b) | ($2.7b) | $4.0b | $867.7m | ($1.3b) | ($5.7b) | — | |
| Interest Expense | $2.4b | $2.2b | — | ($2.5b) | ($6.7b) | $14.0b | $3.3b | $4.2b | $5.4b | $5.2b | |
| Interest Expense On Lease Liabilities | — | — | — | ($128.4m) | $189.2m | ($198.2m) | $221.0m | $279.0m | $261.0m | — | |
| Non-Operating Income (Expense) | — | $314.9m | $1.0b | $2.4b | $750.7m | $1.5b | $507.3m | $1.8b | $978.0m | $3.2b | |
| Other Finance Cost | $201.5m | $849.5m | — | — | — | — | — | — | — | — | |
| Other Operating Income Expense | ($3.9b) | ($854.9m) | $90.9m | ($2.0b) | ($7.2b) | ($1.1b) | ($1.8b) | ($966.0m) | ($2.1b) | — | |
| Other expenses | — | ($1.2b) | ($554.7m) | ($4.4b) | ($7.9b) | ($2.7b) | ($2.3b) | ($2.7b) | ($3.0b) | ($1.3b) | |
| Research And Development Expense | $162.0m | $167.5m | $199.8m | $247.7m | $250.6m | $296.6m | $374.5m | $383.0m | $463.0m | — | |
| Selling Expense | $7.2m | — | — | — | — | — | — | — | — | — | |
| Selling, General and Administrative Expense | ($2.9b) | ($3.1b) | ($3.4b) | $4.3b | $4.1b | ($4.9b) | ($5.3b) | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.